JP2008528512A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008528512A5 JP2008528512A5 JP2007552375A JP2007552375A JP2008528512A5 JP 2008528512 A5 JP2008528512 A5 JP 2008528512A5 JP 2007552375 A JP2007552375 A JP 2007552375A JP 2007552375 A JP2007552375 A JP 2007552375A JP 2008528512 A5 JP2008528512 A5 JP 2008528512A5
- Authority
- JP
- Japan
- Prior art keywords
- kda
- molecular weight
- isolated
- polypeptide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64610605P | 2005-01-21 | 2005-01-21 | |
| PCT/US2006/002474 WO2006079076A2 (en) | 2005-01-21 | 2006-01-20 | Yersinia spp. polypeptides and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012209231A Division JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008528512A JP2008528512A (ja) | 2008-07-31 |
| JP2008528512A5 true JP2008528512A5 (https=) | 2009-03-12 |
Family
ID=36649588
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007552375A Withdrawn JP2008528512A (ja) | 2005-01-21 | 2006-01-20 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
| JP2012209231A Expired - Fee Related JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
| JP2015139060A Expired - Lifetime JP6224655B2 (ja) | 2005-01-21 | 2015-07-10 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012209231A Expired - Fee Related JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
| JP2015139060A Expired - Lifetime JP6224655B2 (ja) | 2005-01-21 | 2015-07-10 | エルシニアｓｐｐ．ポリペプチド及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US8563004B2 (https=) |
| EP (3) | EP1848732B1 (https=) |
| JP (3) | JP2008528512A (https=) |
| CN (1) | CN101142230A (https=) |
| AU (1) | AU2006206234B2 (https=) |
| BR (1) | BRPI0606506A2 (https=) |
| CA (1) | CA2595163A1 (https=) |
| DK (1) | DK1848732T3 (https=) |
| ES (1) | ES2588010T3 (https=) |
| MX (1) | MX2007008723A (https=) |
| NZ (1) | NZ556651A (https=) |
| WO (1) | WO2006079076A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0749321T3 (da) * | 1994-02-09 | 2007-03-12 | Epitopix Llc | Aktiv immunisering under anvendelse af et sideroforreceptorprotein |
| US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| MXPA03006038A (es) | 2001-01-03 | 2005-02-14 | Willmar Poultry Co Inc | Composiciones inmunizantes y metodos de uso. |
| AU2004274977B2 (en) | 2003-09-19 | 2011-06-23 | Epitopix, Llc | Campylobacter polypeptides and methods of use |
| NZ556651A (en) | 2005-01-21 | 2010-05-28 | Epitopix Llc | Yersinia spp. polypeptides and methods of use |
| SG10201604103SA (en) * | 2011-05-31 | 2016-07-28 | Hutchison Biofilm Medical Solutions Ltd | Dispersion and detachment of cell aggregates |
| US9631221B1 (en) | 2011-09-02 | 2017-04-25 | Becton, Dickinson And Company | Identification of microorganisms using MALDI-TOF-MS on-plate extraction |
| KR20140068105A (ko) | 2011-12-29 | 2014-06-05 | 타오 헬스 라이프 파마 가부시키가이샤 | 아밀로스페로이드가 결합하여 성숙 신경 세포사를 유발하는 표적 분자, 아밀로스페로이드가 유도하는 신경 세포사를 억제하는 방법 및 물질, 및 그들의 이용 |
| US9701760B2 (en) * | 2012-02-13 | 2017-07-11 | National University Corporation Kyoto Institute Of Technology | Peptide having affinity for silicon nitride (Si3N4), and use therefor |
| US8753643B1 (en) | 2012-04-11 | 2014-06-17 | Life-Science Innovations, Llc | Spray dried compositions and methods of use |
| US9017953B2 (en) * | 2012-05-18 | 2015-04-28 | Washington University | Biomarker and therapeutic for urinary tract infection |
| RU2549712C1 (ru) * | 2013-11-26 | 2015-04-27 | Федеральное казенное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | CПОСОБ ВЫДЕЛЕНИЯ ИНГИБИТОРА СЕКРЕЦИИ СИДЕРОФОРОВ, СИНТЕЗИРУЕМОГО pgm- ШТАММАМИ Y. pestis И ВЫДЕЛЕННЫЙ ИНГИБИТОР |
| FR3024903A1 (fr) | 2014-08-14 | 2016-02-19 | Biomerieux Sa | Procede de quantification d'au moins un groupe de microorganismes par spectrometrie de masse |
| US11345977B2 (en) * | 2014-10-10 | 2022-05-31 | Rare Element Resources Ltd. | Processing for the extraction of rare earth elements |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| WO2017083367A1 (en) | 2015-11-09 | 2017-05-18 | Epitopix, Llc | Polypeptides of fusobacterium and methods of use |
| US10166280B2 (en) | 2016-06-08 | 2019-01-01 | Epitopix, Llc | Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use |
| ES2945137T3 (es) | 2017-02-10 | 2023-06-28 | Epitopix Llc | Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso |
| CN113613677A (zh) * | 2019-10-18 | 2021-11-05 | 犹他大学研究基金会 | 聚合物药物递送缀合物及其制备方法和使用方法 |
| CN113679829B (zh) * | 2020-05-18 | 2024-01-02 | 北京繁易纳维科技有限公司 | 一种预防癌症术后复发的肿瘤疫苗及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420253A (en) | 1993-09-09 | 1995-05-30 | Willmar Poultry Company, Inc. | Method for purifying egg yolk immunoglobulins |
| US5830479A (en) | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| DK0749321T3 (da) | 1994-02-09 | 2007-03-12 | Epitopix Llc | Aktiv immunisering under anvendelse af et sideroforreceptorprotein |
| WO1995025742A1 (en) | 1994-03-22 | 1995-09-28 | Pfizer Inc. | Pasteurellaceae antigens and related vaccines |
| US5538733A (en) | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
| WO1998024912A2 (en) * | 1996-12-04 | 1998-06-11 | Heska Corporation | Recombinant plague vaccine |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6610836B1 (en) | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
| CA2404260A1 (en) | 2000-03-21 | 2001-09-27 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
| MXPA03006038A (es) | 2001-01-03 | 2005-02-14 | Willmar Poultry Co Inc | Composiciones inmunizantes y metodos de uso. |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0127657D0 (en) * | 2001-11-19 | 2002-01-09 | Microscience Ltd | Virulence genes and proteins and their use |
| US20060057160A1 (en) | 2002-08-02 | 2006-03-16 | Ralph Biemans | Vaccine composition |
| AU2004274977B2 (en) | 2003-09-19 | 2011-06-23 | Epitopix, Llc | Campylobacter polypeptides and methods of use |
| CA2574375C (en) | 2004-07-23 | 2015-03-17 | Chiron Srl | Polypeptides for oligomeric assembly of antigens |
| US9458204B2 (en) | 2004-08-25 | 2016-10-04 | Epitopix Llc | Fusobacterium polypeptides and methods of use |
| NZ556651A (en) * | 2005-01-21 | 2010-05-28 | Epitopix Llc | Yersinia spp. polypeptides and methods of use |
| JP2008530245A (ja) * | 2005-02-18 | 2008-08-07 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | 尿路病原性菌株由来の抗原 |
| US20120263724A1 (en) * | 2005-04-20 | 2012-10-18 | Manohar John | Escherichia coli o157:h7 proteins and uses thereof |
-
2006
- 2006-01-20 NZ NZ556651A patent/NZ556651A/en not_active IP Right Cessation
- 2006-01-20 CN CNA2006800028566A patent/CN101142230A/zh active Pending
- 2006-01-20 DK DK06719369.8T patent/DK1848732T3/en active
- 2006-01-20 BR BRPI0606506-6A patent/BRPI0606506A2/pt not_active Application Discontinuation
- 2006-01-20 CA CA002595163A patent/CA2595163A1/en not_active Abandoned
- 2006-01-20 MX MX2007008723A patent/MX2007008723A/es active IP Right Grant
- 2006-01-20 JP JP2007552375A patent/JP2008528512A/ja not_active Withdrawn
- 2006-01-20 EP EP06719369.8A patent/EP1848732B1/en not_active Expired - Lifetime
- 2006-01-20 ES ES06719369.8T patent/ES2588010T3/es not_active Expired - Lifetime
- 2006-01-20 EP EP11075020A patent/EP2361926A3/en not_active Withdrawn
- 2006-01-20 WO PCT/US2006/002474 patent/WO2006079076A2/en not_active Ceased
- 2006-01-20 AU AU2006206234A patent/AU2006206234B2/en not_active Ceased
- 2006-01-20 US US11/336,706 patent/US8563004B2/en active Active
- 2006-01-20 EP EP11007570A patent/EP2431382A1/en not_active Withdrawn
-
2011
- 2011-01-31 US US13/018,292 patent/US20110206674A1/en not_active Abandoned
-
2012
- 2012-09-24 JP JP2012209231A patent/JP6178059B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-08 US US14/048,649 patent/US9085613B2/en not_active Expired - Lifetime
- 2013-10-08 US US14/048,643 patent/US9109018B2/en not_active Expired - Lifetime
- 2013-10-08 US US14/048,640 patent/US9085612B2/en not_active Expired - Lifetime
-
2015
- 2015-07-07 US US14/793,494 patent/US9221899B2/en not_active Expired - Lifetime
- 2015-07-10 JP JP2015139060A patent/JP6224655B2/ja not_active Expired - Lifetime
- 2015-11-05 US US14/933,899 patent/US9352029B2/en not_active Expired - Lifetime
-
2016
- 2016-04-28 US US15/140,767 patent/US9801932B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008528512A5 (https=) | ||
| Kalach et al. | Helicobacter pylori infection in children | |
| Nagib et al. | Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats | |
| Chowdhury et al. | Natural peste des petits ruminants virus infection in Black Bengal goats: virological, pathological and immunohistochemical investigation | |
| Arakawa et al. | 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications | |
| Pan et al. | Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy | |
| Levendosky et al. | Griffithsin and carrageenan combination to target herpes simplex virus 2 and human papillomavirus | |
| Fradin et al. | Oral cyclosporine for severe chronic idiopathic urticaria and angioedema | |
| KR20240056564A (ko) | T 세포 림프종을 치료하기 위한 약물을 제조하는 데 있어서 ezh2 억제제의 용도 | |
| EA035372B1 (ru) | Флагеллиновые композиции и их применение | |
| McHutchison et al. | Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection | |
| KR102299635B1 (ko) | 염증성 장질환의 치료에 있어서의 아르테미시닌 유도체의 의학적 용도 | |
| Taus et al. | Experimental aerosol infection of cattle (Bos taurus) with ovine herpesvirus 2 using nasal secretions from infected sheep | |
| NZ617196A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels | |
| Huang et al. | Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus | |
| Sauerhering et al. | Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice | |
| JP2018524354A (ja) | 大腸炎を処置する方法 | |
| Jayaraj et al. | CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson’s disease mice | |
| Branche et al. | Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection | |
| Manns et al. | Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase II b and III studies | |
| KR102548616B1 (ko) | 관중 유래 화합물 또는 이의 유도체를 포함하는 코로나바이러스 감염 예방 및 치료용 약학 조성물 | |
| Adiliaghdam et al. | Targeting bacterial quorum sensing shows promise in improving intestinal barrier function following burn-site infection | |
| JP2013510158A5 (https=) | ||
| CN115697354A (zh) | 用于治疗sars-cov-2感染的组合物和方法 | |
| Nikunjkumar et al. | Ribavirin as a curative and prophylactic agent against foot and mouth disease virus infection in C57BL/6 suckling and adult mice model |